UPDate: ANZUP Newsletter

September 2009 volume 1 issue 1

Contents

PAGE 1

  • Message from the Chair

PAGE 2

  • Key Contacts

PAGE 3

  • Upcoming Meetings

PAGE 4

  • Renal Cell Cancer Subcommittee: Message from the Chair
  • Overview of SORCE Trial
  • Trial Title: A phase III randomised double-blind study comparing sorafenib with placebo in patients with resected primary renal cell carcinoma at high or intermediate risk of relapse
  • ANZUP Cancer Trials Group Subcommittee Expression of interest form

PAGE 5

  • Germ Cell cancer Subcommittee: Message from the Chair
  • Accelerated BEP

PAGE 6

  • Chemo & Cognition Study
  • A phase II multi-centre trial of a seven day Aprepitant schedule for the prevention of chemotherapy induced nausea and vomiting in patients receiving five day cisplatin-based chemotherapy for germ cell tumours.

PAGE 7

  • Prostate Cancer Subcommittee:Message from the Chair
  • RAVES – Randomised Adjuvant versus Early Salvage radiotherapy post-prostatectomy

PAGE 8

  • Bladder cancer subcommittee: Message from chair
  • Pathology, Tissue and Ethics Subcommittee: Message from the chair

PAGE 9

  • Bioinformatics Subcommittee: Message from the Chair
  • Quality of Life and Supportive Care Subcommittee: Message from The Chair

PAGE 10

  • Consumer Advisory Panel/Subcommittee

PAGE 11

  • New membership application